Tech Center 1600 • Art Units: 1645 1647
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18006385 | METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND ALLERGIC DISORDERS | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18114092 | USES OF UROLITHINS | Non-Final OA | Amazentis SA |
| 18011338 | OLFACTORY RECEPTORS FOR USE AS TARGETS FOR ANTIGEN BINDING MOLECULES TO DETECT AND TREAT CANCER | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18566497 | MINICELLS FROM HIGHLY GENOME REDUCED ESCHERICHIA COLI: CYTOPLASMIC AND SURFACE EXPRESSION OF RECOMBINANT PROTEINS AND INCORPORATION IN THE MINICELLS | Non-Final OA | University of Virginia Patent Foundation |
| 18562387 | RECOMBINANT EXPRESSION OF KLEBSIELLA PNEUMONIAE O-ANTIGENS IN ESCHERICHIA COLI | Non-Final OA | Pfizer Inc. |
| 18702767 | LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE | Non-Final OA | INSTITUTO DE SALUD CARLOS III |
| 18694632 | MEDICAMENT FOR KILLING TUMOR CELLS | Non-Final OA | NIPPON MEDICAL SCHOOL FOUNDATION |
| 18604772 | BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS ATM-209 INHIBITING HELICOBACTER PYLORI AND APPLICATION THEREOF | Non-Final OA | SHENZHEN PORSHEALTH BIOENGINEERING CO., LTD. |
| 18291001 | Method for Purification of Botulinum Toxin Complex with Improved Purification Yield | Non-Final OA | INIBIO CO., LTD. |
| 18576556 | METHOD FOR PURIFICATION OF CLOSTRIDIUM BOTULINUM NEUROTOXIN PROTEIN DEPRIVED OF NON-TOXIN PROTEIN | Non-Final OA | PHARMA RESEARCH BIO CO., LTD. |
| 18275463 | VACCINE AND METHODS FOR PREVENTING FILARIASIS AND DIROFILARIASIS | Non-Final OA | PAI LIFE SCIENCES INC. |
| 18259633 | IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SWINE DYSENTERY | Non-Final OA | HIPRA SCIENTIFIC, S.L.U. |
| 18038032 | BACILLUS SUBTILIS STRAIN WITH STRONG INHIBITION OF ENTEROPATHOGENIC AND FOODBORNE PATHOGENIC BACTERIA | Non-Final OA | lowa State University Research Foundation, Inc. |
| 18302656 | METHODS FOR TREATING AUTISM SPECTRUM DISORDER | Non-Final OA | Genevive, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy